{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:45:54Z","timestamp":1785890754910,"version":"3.56.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jtha.2026.03.024","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T15:00:16Z","timestamp":1776783616000},"page":"2627-2639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Natural history of antiplatelet antibody formation in patients with Glanzmann thrombasthenia: a French multicenter prospective study"],"prefix":"10.1016","volume":"24","author":[{"given":"Dominique","family":"Desprez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roseline","family":"d\u2019Oiron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Voisin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Falaise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Alessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Saultier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9raldine","family":"Lavigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Essaydi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Joelle","family":"Apithy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Dupuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Goin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoann","family":"Huguenin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2526-8826","authenticated-orcid":false,"given":"Mathieu","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2026.03.024_bib1","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1160\/TH09-04-0225","article-title":"Glanzmann\u2019s thrombasthenia (defective platelet integrin alphaIIb-beta3): proposals for management between evidence and open issues","volume":"102","author":"Di Minno","year":"2009","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.03.024_bib2","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3324\/haematol.2018.214239","article-title":"Glanzmann thrombasthenia: genetic basis and clinical correlates","volume":"105","author":"Botero","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2026.03.024_bib3","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/ejhg.2012.151","article-title":"Clinical utility gene card for: Glanzmann thrombasthenia","volume":"20","author":"Fiore","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.jtha.2026.03.024_bib4","doi-asserted-by":"crossref","first-page":"5996","DOI":"10.1182\/blood-2011-07-365635","article-title":"Glanzmann thrombasthenia: a review of ITGA2B and ITGB3 defects with emphasis on variants, phenotypic variability, and mouse models","volume":"118","author":"Nurden","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.03.024_bib5","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1002\/humu.22776","article-title":"Expanding the mutation spectrum affecting \u03b1IIb\u03b23 integrin in Glanzmann thrombasthenia: screening of the ITGA2B and ITGB3 genes in a large international cohort","volume":"36","author":"Nurden","year":"2015","journal-title":"Hum Mutat"},{"key":"10.1016\/j.jtha.2026.03.024_bib6","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-1172-1-10","article-title":"Glanzmann thrombasthenia","volume":"1","author":"Nurden","year":"2006","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jtha.2026.03.024_bib7","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s13023-023-02787-2","article-title":"Emergency management of patients with Glanzmann thrombasthenia: consensus recommendations from the French reference center for inherited platelet disorders","volume":"18","author":"Fiore","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jtha.2026.03.024_bib8","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2147\/JBM.S71319","article-title":"Glanzmann\u2019s thrombasthenia: pathogenesis, diagnosis, and current and emerging treatment options","volume":"6","author":"Solh","year":"2015","journal-title":"J Blood Med"},{"key":"10.1016\/j.jtha.2026.03.024_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/jth.15117","article-title":"Immunization against \u03b1IIb \u03b23 and \u03b1v \u03b23 in Glanzmann thrombasthenia patients carrying the French Gypsy mutation","volume":"19","author":"Fiore","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.03.024_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.tmrv.2018.05.002","article-title":"Acquired antibodies to \u03b1IIb\u03b23 in Glanzmann thrombasthenia: from transfusion and pregnancy to bone marrow transplants and beyond","volume":"32","author":"Nurden","year":"2018","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.jtha.2026.03.024_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102253","article-title":"In vitro characterization of rare anti-\u03b1IIb\u03b23 isoantibodies produced by patients with Glanzmann thrombasthenia that severely block fibrinogen binding and generate procoagulant platelets via complement activation","volume":"8","author":"Lee","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.03.024_bib12","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/bjh.15087","article-title":"Anti-\u03b1IIb \u03b23 immunization in Glanzmann thrombasthenia: review of literature and treatment recommendations","volume":"181","author":"Fiore","year":"2018","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2026.03.024_bib13","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1111\/j.1365-2516.2011.02744.x","article-title":"Natural history of platelet antibody formation against \u03b1IIb\u03b23 in a French cohort of Glanzmann thrombasthenia patients","volume":"18","author":"Fiore","year":"2012","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.03.024_bib14","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1182\/blood.2021011595","article-title":"How I manage pregnancy in women with Glanzmann thrombasthenia","volume":"139","author":"Fiore","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.03.024_bib15","doi-asserted-by":"crossref","first-page":"e858","DOI":"10.1111\/j.1365-2516.2011.02516.x","article-title":"A systematic review of the management and outcomes of pregnancy in Glanzmann thrombasthenia","volume":"17","author":"Siddiq","year":"2011","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.03.024_bib16","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood.V75.7.1383.1383","article-title":"Glanzmann\u2019s thrombasthenia: the spectrum of clinical disease","volume":"75","author":"George","year":"1990","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.03.024_bib17","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1538-7836.2004.00767.x","article-title":"International Data Collection on Recombinant Factor VIIa and Congenital Platelet Disorders Study Group. Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann\u2019s thrombasthenia: results of an international survey","volume":"2","author":"Poon","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.03.024_bib18","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1111\/j.1365-2516.2010.02230.x","article-title":"Prevalence of allo-immunization anti-HLA and anti-integrin alphaIIbbeta3 in Glanzmann Thromboasthenia patients","volume":"16","author":"Santoro","year":"2010","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2026.03.024_bib19","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000526224","article-title":"High rates of anti-\u03b1IIb\u03b23 antibodies produced by a Glanzmann thrombasthenia patient after first and unique red blood cells administration","volume":"146","author":"Huguenin","year":"2023","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jtha.2026.03.024_bib20","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1111\/j.1538-7836.2005.01579.x","article-title":"Red blood cell transfusion in patients with type 1 Glanzmann\u2019s thrombasthenia","volume":"3","author":"Laurian","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2026.03.024_bib21","first-page":"384","article-title":"Studies on the binding of an alloimmune and two murine monoclonal antibodies to the platelet glycoprotein IIb-IIIa complex receptor","volume":"107","author":"Coller","year":"1986","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jtha.2026.03.024_bib22","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1182\/blood.V51.6.1065.1065","article-title":"Acquired IgG antibody occurring in a thrombasthenic patient: its effect on human platelet function","volume":"51","author":"Levy-Toledano","year":"1978","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2026.03.024_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s12185-010-0731-5","article-title":"Molecular analysis of a patient with type I Glanzmann thrombasthenia and clinical impact of the presence of anti-\u03b1IIb\u03b23 alloantibodies","volume":"93","author":"Kashiwagi","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1016\/j.jtha.2026.03.024_bib24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3324\/haematol.2018.201665","article-title":"Anti-HLA antibodies with complementary and synergistic interaction geometries promote classical complement activation on platelets","volume":"104","author":"Rijkers","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2026.03.024_bib25","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.3324\/haematol.2022.281973","article-title":"The Glanzmann Thrombasthenia Registry: safety of platelet therapy in patients with Glanzmann thrombasthenia and changes in alloimmunization status","volume":"108","author":"Poon","year":"2023","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2026.03.024_bib26","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/trf.17824","article-title":"Should HLA and HPA-matched platelet transfusions for patients with Glanzmann thrombasthenia or Bernard-Soulier syndrome be standardized care? A Dutch survey and recommendations","volume":"64","author":"Huisman","year":"2024","journal-title":"Transfusion"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362600214X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S153878362600214X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:43:47Z","timestamp":1785887027000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S153878362600214X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S153878362600214X"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2026.03.024","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural history of antiplatelet antibody formation in patients with Glanzmann thrombasthenia: a French multicenter prospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2026.03.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}